Report cover image

Cell Therapy Technologies Market Growth, Size, Trends Analysis - By Product, By Process, By Cell Type, By Application, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Publisher SPER Market Research Pvt. Ltd.
Published Jan 06, 2025
Length 249 Pages
SKU # SPER19520447

Description

Cell Therapy Technologies Market Growth, Size, Trends Analysis - By Product, By Process, By Cell Type, By Application, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034


Cell Therapy Technologies Market Introduction and Overview

According to SPER market research, ‘Global Cell Therapy Technologies Market Size- By Product, By Process, By Cell Type, By Application, By End User – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Cell Therapy Technologies Market is predicted to reach 7.64 billion by 2030 with a CAGR of 11.25%.

The application of machine learning and computational algorithms to the analysis and interpretation of diagnostic data is known as artificial intelligence (AI) in in-vitro diagnostics (IVD). This is done to enhance clinical decision-making, accuracy, and efficiency in laboratory testing and medical diagnostics. Diabetes, heart disease, and cancer are among the chronic illnesses that are becoming more prevalent globally. AI is being used more and more to enhance the effectiveness, accuracy, and customized treatment options for a range of illnesses.

Restraints: Autologous therapies, such as CAR-T, need extremely low temperatures of -196°C to keep cells alive during production and delivery. Any disruption in temperature can lower the effectiveness of the treatment, risking both health and money. Companies like Cryoport help with this process, but their advanced systems raise shipping costs, making treatment less accessible. Additionally, delays in transporting patient-specific cells to and from manufacturing facilities can impact timely treatment.

Scope of the report:

Report Metric Details
Market size available for years 2020-2033
Base year considered 2023
Forecast period 2024-2033
Segments covered By Product, By Process, By Cell Type, By Application, By End User

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered

Danaher Corporation, Merck KGaA, Thermo Fisher Scientific Inc, Lonza, Sartorius AG, Agilent Technologies, Inc, Bio-Techne, Avantor, Inc, Genscript, BD, Corning Incorporated.

Cell Therapy Technologies Market Segmentation:

By Product: Based on the Product, Global Cell Therapy Technologies Market is segmented as; Media, Sera & Reagents, Cell Engineering Products, Cell Culture Vessels, Cell Therapy Equipment, Systems & Software, and Other Products.

By Process: Based on the Process, Global Cell Therapy Technologies Market is segmented as; Cell Processing, Cell Preservation, Cell Distribution, Cell Handling, Process Monitoring & Quality Control.

By Cell Type: Based on the Cell Type, Global Cell Therapy Technologies Market is segmented as; T-Cells, Stem Cells, Other Cells.

By Application: Based on the Application, Global Cell Therapy Technologies Market is segmented as; Cancer, Cardiovascular Disease, Orthopedic Disorders, Autoimmune Diseases, Other Applications.

By End User: Based on the End User, Global Cell Therapy Technologies Market is segmented as; Biopharmaceutical and Biotechnology Companies, CROs and CMOs, Research Institutes, Cell Banks.

Table of Contents

249 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Cell Therapy Technologies Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Cell Therapy Technologies Market
7. Global Cell Therapy Technologies Market, By Product (USD Million) 2021-2034
7.1. Media
7.2. Sera & Reagents,
7.3. Cell Engineering Products
7.4. Cell Culture Vessels
7.5. Cell Therapy Equipment
7.6. Systems & Software
7.7. Other Products
8. Global Cell Therapy Technologies Market, By Process (USD Million) 2021-2034
8.1. Cell Processing
8.2. Cell Preservation
8.3. Cell Distribution
8.4. Cell Handling
8.5. Process Monitoring & Quality Control
9. Global Cell Therapy Technologies Market, By Cell type (USD Million) 2021-2034
9.1. T-Cells
9.2. Stem cells
10. Global Cell Therapy Technologies Market, By Application (USD Million) 2021-2034
10.1. Cancer
10.2. Cardiovascular disease (CVD)
10.3. Orthopaedic disorders
10.4. Autoimmune diseases
10.5. Other applications
11. Global Cell Therapy Technologies Market, By End User (USD Million) 2021-2034
11.1. Biopharmaceutical & Biotechnology Companies
11.2. CROs & CMOs
11.3. Research Institutes
11.4. Cell Banks
12. Global Cell Therapy Technologies Market (USD Million) 2021-2034
12.1. Global Cell Therapy Technologies Market Size and Market Share
13. Global Cell Therapy Technologies Market, By Region (USD Million) 2021-2034
13.1. Asia-Pacific
13.1.1. Australia
13.1.2. China
13.1.3. India
13.1.4. Japan
13.1.5. South Korea
13.1.6. Rest of Asia-Pacific
13.2. Europe
13.2.1. France
13.2.2. Germany
13.2.3. Italy
13.2.4. Spain
13.2.5. United Kingdom
13.2.6. Rest of Europe
13.3. Middle East and Africa
13.3.1. Kingdom of Saudi Arabia
13.3.2. United Arab Emirates
13.3.3. Qatar
13.3.4. South Africa
13.3.5. Egypt
13.3.6. Morocco
13.3.7. Nigeria
13.3.8. Rest of Middle-East and Africa
13.4. North America
13.4.1. Canada
13.4.2. Mexico
13.4.3. United States
13.5. Latin America
13.5.1. Argentina
13.5.2. Brazil
13.5.3. Rest of Latin America
14. Company Profile
14.1. Danaher Corporation
14.1.1. Company details
14.1.2. Financial outlook
14.1.3. Product summary
14.1.4. Recent developments
14.2. Merck KGaA
14.2.1. Company details
14.2.2. Financial outlook
14.2.3. Product summary
14.2.4. Recent developments
14.3. Thermo Fisher Scientific Inc
14.3.1. Company details
14.3.2. Financial outlook
14.3.3. Product summary
14.3.4. Recent developments
14.4. Lonza
14.4.1. Company details
14.4.2. Financial outlook
14.4.3. Product summary
14.4.4. Recent developments
14.5. Sartorius AG
14.5.1. Company details
14.5.2. Financial outlook
14.5.3. Product summary
14.5.4. Recent developments
14.6. Agilent Technologies, Inc
14.6.1. Company details
14.6.2. Financial outlook
14.6.3. Product summary
14.6.4. Recent developments
14.7. Bio-Techne
14.7.1. Company details
14.7.2. Financial outlook
14.7.3. Product summary
14.7.4. Recent developments
14.8. Avantor, Inc
14.8.1. Company details
14.8.2. Financial outlook
14.8.3. Product summary
14.8.4. Recent developments
14.9. Genscript
14.9.1. Company details
14.9.2. Financial outlook
14.9.3. Product summary
14.9.4. Recent developments
14.10. BD
14.10.1. Company details
14.10.2. Financial outlook
14.10.3. Product summary
14.10.4. Recent developments
14.11. Corning Incorporated
14.11.1. Company details
14.11.2. Financial outlook
14.11.3. Product summary
14.11.4. Recent developments
14.12. Others
15. Conclusion
16. List of Abbreviations
17. Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us